Physician profile
Kia Lor
NPI 1811457310
$3,232.40
in general payments reported to CMS, 2019-2025
11 companies · $246 in 2025
The $246 reported for 2025 was more than what 84% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.88 · 2023: $1,151 · 2024: $1,824 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,949 · Education: $767 · Travel and Lodging: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,949.43 |
| Education | $766.92 |
| Travel and Lodging | $504.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,268.68 | 2023-2024 | Omnia, Senza |
| Boston Scientific Corporation | $632.90 | 2024 | |
| Medtronic, INC. | $274.29 | 2023-2025 | Intellis Adaptivestim, Vectris Surescan, Synchromedii |
| Nalu Medical, INC. | $264.81 | 2023-2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $193.85 | 2024 | Sprint Pns System |
| Globus Medical, INC. | $188.09 | 2025 | Senza |
| Avanos Medical | $182.83 | 2024 | Coolief* Cooled Radiofrequency |
| Saluda Medical Americas, INC. | $116.95 | 2024 | Evoke |
| Vertos Medical, INC. | $66.83 | 2023 | Mild Device Kit |
| Stryker Corporation | $31.29 | 2024 | Spinejack |
| Astrazeneca Pharmaceuticals LP | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kia Lor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.